Stux Capital Management’s Pfizer PFE Stock Holding History

Stux Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$15M	Buy	532,902 +199,522	+60%	+$5.69M	1.96%	2
2014 Q1	$10.2M	Sell	333,380 -18,024	-5%	-$537K	1.25%	6
2013 Q4	$10.2M	Sell	351,404 -183,923	-34%	-$5.35M	1.21%	11
2013 Q3	$14.6M	Sell	535,327 -57,225	-10%	-$1.56M	1.94%	3
2013 Q2	$15.7M	Buy	+592,552	New	+$16.4M	1.98%	5

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Stux Capital Management's PFE Position: Q2 2014 in Review

Stux Capital Management increased its Pfizer (PFE) stake by 60% in Q2 2014, buying an estimated $5.69M and bringing the position to 532,902 shares worth $15M. The position accounts for 1.96% of the portfolio, ranked #2.

Stux Capital Management first reported a position in PFE in Q2 2013 and has held it in 5 quarters since. The position peaked at $15.7M in Q2 2013. 1,747 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

Stux Capital Management held 532,902 shares of Pfizer worth $15M as of Q2 2014.
Stux Capital Management bought 199,522 Pfizer shares in Q2 2014, an estimated $5.69M.
Pfizer made up 1.96% of Stux Capital Management's portfolio in Q2 2014, its #2 holding.
Stux Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 5 quarters since.
Stux Capital Management's Pfizer position peaked at $15.7M in Q2 2013.
1,747 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Stux Capital Management's 13F filing for Q2 2014, filed 14 Jul 2014.